Skip to main content
OpenTrials

Clinical trial condition

Herpes Zoster Vaccine

Explore clinical trials studying Herpes Zoster Vaccine. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Herpes Zoster Vaccine trial results

Completed

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

NCT02723773

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 161 locations
View Trial Details
Completed

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

NCT02075515

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Milford, Massachusetts, United States
  • GSK Investigational Site Ghent, Belgium
View Trial Details
Completed

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

NCT02045836

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Columbia, Maryland, United States
  • GSK Investigational Site Coquitlam, British Columbia, Canada
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

NCT01798056

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Toronto, Ontario, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Prague, Czechia
View all 28 locations
View Trial Details
Completed

Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy

NCT01772160

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Cavallino (LE), Apulia, Italy
  • GSK Investigational Site Copertino (LE), Apulia, Italy
  • GSK Investigational Site Cutrofiano (LE), Apulia, Italy
  • GSK Investigational Site Galatina (LE), Apulia, Italy
View all 43 locations
View Trial Details
Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

NCT01165229

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 213 locations
View Trial Details

Related conditions